165 related articles for article (PubMed ID: 33289300)
1. Multidrug-resistant Proteus mirabilis isolates carrying bla
Kang Q; Wang X; Zhao J; Liu Z; Ji F; Chang H; Yang J; Hu S; Jia T; Wang X; Tang J; Dong G; Hu G; Wang J; Zhang Y; Qin J; Wang C
Integr Zool; 2021 Nov; 16(6):798-809. PubMed ID: 33289300
[TBL] [Abstract][Full Text] [Related]
2. First report of bla
Leulmi Z; Kandouli C; Mihoubi I; Benlabed K; Lezzar A; Rolain JM
J Glob Antimicrob Resist; 2019 Mar; 16():125-129. PubMed ID: 30217548
[TBL] [Abstract][Full Text] [Related]
3. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.
ElTaweel M; Said HS; Barwa R
Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053
[TBL] [Abstract][Full Text] [Related]
4. A Novel SXT/R391 Integrative and Conjugative Element Carries Two Copies of the
He J; Sun L; Zhang L; Leptihn S; Yu Y; Hua X
mSphere; 2021 Aug; 6(4):e0058821. PubMed ID: 34378988
[TBL] [Abstract][Full Text] [Related]
5. atpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis.
Algammal AM; Hashem HR; Alfifi KJ; Hetta HF; Sheraba NS; Ramadan H; El-Tarabili RM
Sci Rep; 2021 May; 11(1):9476. PubMed ID: 33947875
[TBL] [Abstract][Full Text] [Related]
6. Genetic characteristics of chromosomally integrated carbapenemase gene (bla
Wang Q; Dong K; Liu X; Li W; Bian Q
BMC Microbiol; 2024 Jun; 24(1):216. PubMed ID: 38890647
[TBL] [Abstract][Full Text] [Related]
7. Genomic characterisation of a Proteus mirabilis clinical isolate from China carrying bla
Sun L; Xu J; He F
J Glob Antimicrob Resist; 2019 Dec; 19():317-319. PubMed ID: 31698108
[TBL] [Abstract][Full Text] [Related]
8. Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolates.
Siebor E; Neuwirth C
J Antimicrob Chemother; 2014 Dec; 69(12):3216-20. PubMed ID: 25114166
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug-Resistant
Rubic Z; Soprek S; Jelic M; Novak A; Goic-Barisic I; Radic M; Tambic-Andrasevic A; Tonkic M
Microb Drug Resist; 2021 Feb; 27(2):162-169. PubMed ID: 32429775
[TBL] [Abstract][Full Text] [Related]
10. Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne
Ramos AC; Cayô R; Carvalhaes CG; Jové T; da Silva GP; Sancho FMP; Chagas-Neto T; Medeiros EAS; Gales AC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158274
[TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum β-lactamase-producing Proteus mirabilis with multidrug resistance isolated from raw chicken in Singapore: Genotypic and phenotypic analysis.
Guo S; Aung KT; Tay MYF; Seow KLG; Ng LC; Schlundt J
J Glob Antimicrob Resist; 2019 Dec; 19():252-254. PubMed ID: 31639544
[TBL] [Abstract][Full Text] [Related]
12. First report of extensively-drug-resistant Proteus mirabilis isolate carrying plasmid-mediated bla
Kanzari L; Ferjani S; Saidani M; Hamzaoui Z; Jendoubi A; Harbaoui S; Ferjani A; Rehaiem A; Boutiba Ben Boubaker I; Slim A
Int J Antimicrob Agents; 2018 Dec; 52(6):906-909. PubMed ID: 29958975
[TBL] [Abstract][Full Text] [Related]
13. Virulence factors of Proteus mirabilis clinical isolates carrying bla
Beltrão EMB; Oliveira ÉM; Scavuzzi AML; Firmo EF; Lopes ACS
J Infect Chemother; 2022 Mar; 28(3):363-372. PubMed ID: 34815168
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic profiles of virulence factors and antimicrobial resistance of Proteus mirabilis isolated from chicken carcasses: potential zoonotic risk.
Sanches MS; Baptista AAS; de Souza M; Menck-Costa MF; Koga VL; Kobayashi RKT; Rocha SPD
Braz J Microbiol; 2019 Jul; 50(3):685-694. PubMed ID: 31049879
[TBL] [Abstract][Full Text] [Related]
15. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B
J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
[TBL] [Abstract][Full Text] [Related]
16. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
[TBL] [Abstract][Full Text] [Related]
17. Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of
Alabi OS; Mendonça N; Adeleke OE; da Silva GJ
Afr Health Sci; 2017 Jun; 17(2):356-365. PubMed ID: 29062330
[TBL] [Abstract][Full Text] [Related]
18. Characterization and risk assessment of novel SXT/R391 integrative and conjugative elements with multidrug resistance in
Han Y; Gao Y-F; Xu H-t; Li J-P; Li C; Song C-L; Lei C-W; Chen X; Wang Q; Ma B-H; Wang H-N
Microbiol Spectr; 2024 Feb; 12(2):e0120923. PubMed ID: 38197656
[No Abstract] [Full Text] [Related]
19. Genomic context of resistance genes within a French clinical MDR Proteus mirabilis: identification of the novel genomic resistance island GIPmi1.
Siebor E; de Curraize C; Neuwirth C
J Antimicrob Chemother; 2018 Jul; 73(7):1808-1811. PubMed ID: 29669108
[TBL] [Abstract][Full Text] [Related]
20. Epidemic characteristics of the SXT/R391 integrated conjugative elements in multidrug-resistant Proteus mirabilis isolated from chicken farm.
Ma S; Shen J; Xu Y; Ding P; Gao X; Pan Y; Wu H; Hu G; He D
Poult Sci; 2023 Jun; 102(6):102640. PubMed ID: 37068352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
